Global Rapid Microbiology Testing Market 2023
According to the latest research, the global rapid microbiology testing market is poised to grow by USD 3.3 billion during 2023-2029, progressing at a CAGR of 8.6% during the forecast period.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, method, application, and region. The global market data on rapid microbiology testing can be segmented by product: consumables, instruments, reagents & kits. The instruments segment held the largest share of the global rapid microbiology testing market in 2022 and is anticipated to hold its share during the forecast period. Rapid microbiology testing market is further segmented by method: cellular component-based, growth-based, nucleic acid-based, viability-based, others. Globally, the growth-based segment made up the largest share of the rapid microbiology testing market. Based on application, the rapid microbiology testing market is segmented into: clinical diagnosis, cosmetics and personal care, environmental, food and beverages, pharmaceuticals and biologics, research, others. The clinical segment was the largest contributor to the global rapid microbiology testing market in 2022. On the basis of region, the rapid microbiology testing market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America is estimated to account for the largest share of the global rapid microbiology testing market.
The instruments market is further segmented into automated ID and AST systems, mass spectrometers, PCR systems, cytometers, active air samplers, bioluminescence- and fluorescence-based detection systems, others. In 2022, the automated ID and AST systems segment made up the largest share of revenue generated by the rapid microbiology testing market. Furthermore, the reagents & kits market has been categorized into sterility testing reagents & kits, others. Among these, the sterility testing reagents & kits segment was accounted for the highest revenue generator in 2022.
The global rapid microbiology testing market is highly competitive. Key companies profiled in the report include Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA , Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Don Whitley Scientific Limited, Merck KGaA, Neogen Corporation, Quidel Corporation, Rapid Micro Biosystems Inc., Sartorius Group AG, Thermo Fisher Scientific Inc., TSI Incorporated.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook